
Medical Device R&D and Manufacturer


Source: Medical Device Business Review
On September 9, 2025, Johnson & Johnson announced the election of John Morikis, Chairman, President, and Chief Executive Officer of Sherwin-Williams, as a member of the Board of Directors.
Johnson & Johnson has a 12-member board of directors.The seat includes members covering cross-industry leaders such as the Vice Chairman of JPMorgan Chase and the former Global Chairman and CEO of Ernst & Young. John Morikis's personal profile has been simultaneously updated on the Johnson & Johnson official website.

Source: Johnson & Johnson official website
Morikis is one of the iconic figures in the coatings industry, having led Sherwin-Williams' strategic transformation. Joining Sherwin-Williams in 1984 as a management trainee for the paint store group, he completed a 40-year career leap from the grassroots to the top level: serving as division president, group president, and officially becoming group president in 2016 (after serving as president and chief operating officer for a decade). Under his leadership, the company expanded its global business to 123 countries, optimized the supply chain, and invested in technology to enhance customer experience and operational efficiency.
In the global coatings industry, Sherwin-Williams has established a century-old product standard that has yet to be surpassed.It is the largest and most comprehensive professional coatings manufacturer in the United States and a leader in the global coatings industry, with a market share of over 70% in the U.S. coatings market; its annual production of architectural coatings exceeds 1 million tons, which is almost equivalent to the total annual output of the entire Chinese market, ranking among the top three in the global coatings industry.
Among the top 500 companies ranked by Fortune Magazine in the U.S., 95% are clients of Xuanwei Company, serving hundreds of global OEMs such as Microsoft, Motorola, IBM, Nokia, Kodak, Acer, Hitachi, HP, Lucent, Sun, and AVAYA.
"We warmly welcome John to join our company's board of directors," said Chairman and CEO Joaquin Duato.He is an experienced leader of large multinational companies, with a deep understanding of global markets and complex supply chains. His unique perspective and ability to drive technology-driven innovation will be a valuable asset for Johnson & Johnson as we continue to deliver next-generation medical innovations to patients.”
John Morikis said, "I have always admired Johnson & Johnson's innovation, leadership, and commitment to patients worldwide in the healthcare field. I am honored to join the Johnson & Johnson Board of Directors and look forward to collaborating with the management team and other directors to support the company’s long-term strategy of delivering breakthrough treatments to patients and creating value for shareholders."
The content of this article is for reference only and does not constitute investment advice. Readers are advised to effectively distinguish.If any platform reprints this article, it must take responsibility for the content of the article itself. Medical Device Business Review is not responsible for the impact of secondary dissemination caused by reprints.


If you find the content helpful, welcomeStarred、Like、Forward!
Your support is our greatest motivation



